Vaccinex's Series B Round

Vaccinex raised a round of funding on February 21, 2008.

Vaccinex is a privately held clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies and other targeted biological therapies. A Vaccine…

Articles about Vaccinex's Series B Round: